A randomised, open-label, multifactorial, multicentre, platform trial using a range of repurposed anti-inflammatory treatment to improve outcomes in patients with bronchiectasis not due to cystic fibrosis, within the EMBARC international clinical research network. (AIR-NET)

Research summary

A randomised, open-label, multifactorial, multicentre, platform trial using a range of repurposed anti-inflammatory treatments to improve outcomes in patients with bronchiectasis not due to cystic fibrosis, within the EMBARC international clinical research network.

Principal Investigator

Dr William Flowers

Contact us

Email: catherine.borg@ouh.nhs.uk

Phone: 01865227242

IRAS number

1010124